$1.35
0.043.05%
最終更新: Oct 13, 4:50 PM
$1.37
0.064.58%
Benzinga
Benzinga
Benzinga
水曜日, 10 14
Benzinga
© 2026 Benzinga | All Rights Reserved
Alzamend Neuro (ALZN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.56 | $-0.67 | $-1.45 | $-1.51 |
| Actual | $-0.68 | $-0.74 | $-0.58 | $-0.30 |
| Surprise | -21.4% | -10.4% | +60.0% | +80.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.23 | $-0.22 | $-0.22 | $-0.22 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q1 | Sep 10, 2026 | $-0.68 | $-0.56 | -21.4 % |
| Q4 | Jul 22, 2026 | $-0.74 | $-0.67 | -10.4 % |
| Q3 | Mar 11, 2026 | $-0.58 | $-1.45 | 60.0 % |
| Q2 | Dec 9, 2025 | $-0.30 | $-1.51 | 80.1 % |